Plasma Kinetic Resection of Prostate Combined Terazosin for Treatment of BPH Patient with Coexisting Hypertension  

作　　者：Ming Zheng Mingqiang Zeng Chonghe Jiang Jinyang Chen Shuren Li Jiaxin Wang 

机构地区：[1]Department of Urology, Qingyuan City People’s Hospital of Jinan University, Qingyuan, China [2]Department of Urology, Xiangtan Hospital of Nanhua University, Xiangtan, China

出　　处：《Open Journal of Urology》2014年第5期57-62,共6页泌尿学期刊（英文）

摘　　要：Objective: To evaluate the efficacy and safety of terazosin and plasma kinetic resection of the prostate (PKRP) in the treatment of benign prostatic hyperplasia (BPH) patients with coexisting hypertension. Methods: A total of 205 men who suffered from BPH with concomitant hypertension were enrolled in this study. They all received PKRP surgery and terazosin medication from one week before to 3 months after the operation. The procedures of efficacy and safety were evaluated by analysis of the changes in blood pressures, IPSS, Qmax and the drug related adverse events 4 weeks and 3 months after the operation. Results: The systolic blood pressure decreased from 161 ± 12.33 mmHg at baseline to 148 ± 7.27 mmHg four weeks (P?P?P?P?P?P?Objective: To evaluate the efficacy and safety of terazosin and plasma kinetic resection of the prostate (PKRP) in the treatment of benign prostatic hyperplasia (BPH) patients with coexisting hypertension. Methods: A total of 205 men who suffered from BPH with concomitant hypertension were enrolled in this study. They all received PKRP surgery and terazosin medication from one week before to 3 months after the operation. The procedures of efficacy and safety were evaluated by analysis of the changes in blood pressures, IPSS, Qmax and the drug related adverse events 4 weeks and 3 months after the operation. Results: The systolic blood pressure decreased from 161 ± 12.33 mmHg at baseline to 148 ± 7.27 mmHg four weeks (P?P?P?P?P?P?P

关 键 词：Benign PROSTATIC Hyperplasia HYPERTENSION TERAZOSIN PLASMA KINETIC Vaporization of the PROSTATE 

分 类 号：R73[医药卫生—肿瘤]